Cargando…
Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches
Spondias mangifera is a drupaceous fruit popular for its flavour and health advantages. There is little scientific knowledge about S. mangifera, despite its widespread usage in traditional medicine, in the North-Eastern region of India. Inhibiting the key carbohydrate hydrolysing enzymes is one of t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880729/ https://www.ncbi.nlm.nih.gov/pubmed/35214895 http://dx.doi.org/10.3390/plants11040562 |
_version_ | 1784659291720908800 |
---|---|
author | Khalid, Mohammad Alqarni, Mohammed H. Alsayari, Abdulrhman Foudah, Ahmed I. Aljarba, Tariq M. Mukim, Mohammad Alamri, Mubarak A. Abullais, Shahabe Saquib Wahab, Shadma |
author_facet | Khalid, Mohammad Alqarni, Mohammed H. Alsayari, Abdulrhman Foudah, Ahmed I. Aljarba, Tariq M. Mukim, Mohammad Alamri, Mubarak A. Abullais, Shahabe Saquib Wahab, Shadma |
author_sort | Khalid, Mohammad |
collection | PubMed |
description | Spondias mangifera is a drupaceous fruit popular for its flavour and health advantages. There is little scientific knowledge about S. mangifera, despite its widespread usage in traditional medicine, in the North-Eastern region of India. Inhibiting the key carbohydrate hydrolysing enzymes is one of the strategies for managing diabetes. Therefore, this study studied the antioxidant and anti-diabetic properties of different fraction S. mangifera fruit extract (SMFFs) from Indian geographical origin by in vitro experimental assays and silico docking simulation studies. The ADMET prediction for active substances was also investigated using the AdmetSAR database. Based on the binding affinity/molecular interactions between phytocompounds and target enzymes, in silico investigations were done to confirm the in vitro enzymatic inhibitory capability. β-sitosterol in EtOH-F was analysed using RP-HPLC with RP-C18 column as stationary phase and photo diode array detector. The percentage of β-sitosterol was found to be 1.21% ± 0.17% of total weight of extract (w/w). S. mangifera fruit ethanolic extract had a significant inhibitory concentration of 50% against free radicals produced by ABTS (89.71 ± 2.73%) and lipid peroxidation assay (88.26 ± 2.17%) tests. Similarly, the in vitro antidiabetic test findings indicated that S. mangifera inhibited alpha-amylase (73.42 ± 2.01%) and alpha-glucosidase (79.23 ± 1.98%) enzymes dose-dependently. The maximum glycosylated Hb percentage inhibitory activity shown in the ethanolic fraction was (83.97 ± 2.88%) at 500 µg/mL. The glucose uptake of the ethanolic fraction by the yeast cell showed significant (p < 0.05) at 500 µg/mL when compared with metformin (91.37 ± 1.59%), whereas the other fraction did not show the uptake of glucose by the yeast cell at the same concentration. In the docking study, the main phytoconstituents of S. mangifera fruit, such as oleanolic acid, beta-sitosterol, and beta amyrin, show strong affinity for pancreatic α-amylase. These results imply that S. mangifera has α-amylase and α-glucosidase inhibitory properties and may be used as antidiabetic with antioxidant characteristics. |
format | Online Article Text |
id | pubmed-8880729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88807292022-02-26 Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches Khalid, Mohammad Alqarni, Mohammed H. Alsayari, Abdulrhman Foudah, Ahmed I. Aljarba, Tariq M. Mukim, Mohammad Alamri, Mubarak A. Abullais, Shahabe Saquib Wahab, Shadma Plants (Basel) Article Spondias mangifera is a drupaceous fruit popular for its flavour and health advantages. There is little scientific knowledge about S. mangifera, despite its widespread usage in traditional medicine, in the North-Eastern region of India. Inhibiting the key carbohydrate hydrolysing enzymes is one of the strategies for managing diabetes. Therefore, this study studied the antioxidant and anti-diabetic properties of different fraction S. mangifera fruit extract (SMFFs) from Indian geographical origin by in vitro experimental assays and silico docking simulation studies. The ADMET prediction for active substances was also investigated using the AdmetSAR database. Based on the binding affinity/molecular interactions between phytocompounds and target enzymes, in silico investigations were done to confirm the in vitro enzymatic inhibitory capability. β-sitosterol in EtOH-F was analysed using RP-HPLC with RP-C18 column as stationary phase and photo diode array detector. The percentage of β-sitosterol was found to be 1.21% ± 0.17% of total weight of extract (w/w). S. mangifera fruit ethanolic extract had a significant inhibitory concentration of 50% against free radicals produced by ABTS (89.71 ± 2.73%) and lipid peroxidation assay (88.26 ± 2.17%) tests. Similarly, the in vitro antidiabetic test findings indicated that S. mangifera inhibited alpha-amylase (73.42 ± 2.01%) and alpha-glucosidase (79.23 ± 1.98%) enzymes dose-dependently. The maximum glycosylated Hb percentage inhibitory activity shown in the ethanolic fraction was (83.97 ± 2.88%) at 500 µg/mL. The glucose uptake of the ethanolic fraction by the yeast cell showed significant (p < 0.05) at 500 µg/mL when compared with metformin (91.37 ± 1.59%), whereas the other fraction did not show the uptake of glucose by the yeast cell at the same concentration. In the docking study, the main phytoconstituents of S. mangifera fruit, such as oleanolic acid, beta-sitosterol, and beta amyrin, show strong affinity for pancreatic α-amylase. These results imply that S. mangifera has α-amylase and α-glucosidase inhibitory properties and may be used as antidiabetic with antioxidant characteristics. MDPI 2022-02-21 /pmc/articles/PMC8880729/ /pubmed/35214895 http://dx.doi.org/10.3390/plants11040562 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Khalid, Mohammad Alqarni, Mohammed H. Alsayari, Abdulrhman Foudah, Ahmed I. Aljarba, Tariq M. Mukim, Mohammad Alamri, Mubarak A. Abullais, Shahabe Saquib Wahab, Shadma Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches |
title | Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches |
title_full | Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches |
title_fullStr | Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches |
title_full_unstemmed | Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches |
title_short | Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches |
title_sort | anti-diabetic activity of bioactive compound extracted from spondias mangifera fruit: in-vitro and molecular docking approaches |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880729/ https://www.ncbi.nlm.nih.gov/pubmed/35214895 http://dx.doi.org/10.3390/plants11040562 |
work_keys_str_mv | AT khalidmohammad antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT alqarnimohammedh antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT alsayariabdulrhman antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT foudahahmedi antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT aljarbatariqm antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT mukimmohammad antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT alamrimubaraka antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT abullaisshahabesaquib antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches AT wahabshadma antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches |